Related Experiment Videos
An inexpensive spacer for use with metered-dose bronchodilators in young asthmatic children
Insights
A modified 1-liter plastic bottle effectively delivered bronchodilator medication to children with acute asthma. This low-cost spacer demonstrated significant bronchodilation, proving a viable alternative for acute asthma treatment.
Area of Science:
- Pediatric Pulmonology
- Medical Device Innovation
- Emergency Medicine
Background:
- Metered-dose inhalers (MDIs) are crucial for asthma management.
- Spacers improve MDI medication delivery, especially in children.
- Access to commercial spacers can be limited or costly.
Purpose of the Study:
- To evaluate the efficacy of a modified 1-liter plastic bottle as a low-cost spacer for metered-dose bronchodilators.
- To assess the effectiveness of this DIY spacer in children experiencing acute asthma attacks.
Main Methods:
- A 1-liter plastic soft drink bottle was adapted as a spacer device.
- Twenty-two children (3.9-7.5 years) with acute asthma were enrolled.
- Participants received aerosolized salbutamol or placebo via the modified bottle in a randomized controlled trial.
Main Results:
- Children receiving salbutamol via the plastic bottle spacer showed significantly improved bronchodilation compared to placebo.
- No significant adverse effects were reported during the study.
- The modified bottle demonstrated effective delivery of bronchodilator medication.
Conclusions:
- A 1-liter plastic bottle can serve as a convenient, inexpensive, and effective spacer for metered-dose bronchodilators.
- This approach offers a practical solution for delivering asthma medication to children, particularly in resource-limited settings.
- The modified bottle is a promising tool for managing acute asthma in pediatric populations.
Abstract:
A 1-liter soft drink plastic bottle was modified as a spacer for use with a metered-dose bronchodilator. Its efficacy was tested on 22 children aged 3.9-7.5 years who had acute asthma. They were randomly selected to receive aerosolized salbutamol or placebo via the plastic bottle. Children who received the salbutamol showed significantly greater degree of bronchodilation than those who received the placebo. No significant adverse effects were observed. Cylindrical plastic bottles of 1-liter capacity may thus be used as a convenient and cheap spacer to effectively deliver metered-dose bronchodilators to children during acute asthma.